Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (‘SEBI Listing Regulations’), Arvaya Healthcare has informed that a Meeting of the Board of Directors of the Company is scheduled to be held on Saturday, July 11, 2026 to, consider and approve: 1. To consider & approve Acquisition of Sushodha Institute of Gastroenterology and approval of Material Related Party Transactions with Bidari Kotresh Anilkumar. 2. To consider and evaluate a proposal for issuance of equity shares on a preferential basis for consideration other than cash (share swap). 3. To constitute Right Issue Committee of a Company. 4. To consider proposal to issue securities to the existing shareholders of the Company on Rights Basis, as may be permitted under applicable law, subject to such regulatory/statutory approvals as may be required. 5. To consider the approval for the postal ballot process and related actions. Further to its communication dated June 22, 2026 the trading window will be closed from July 1, 2026 which shall remain closed till 48 hours after the declaration of Unaudited Financial Results of the Company for the First Quarter ended June 30, 2026.
The above information is a part of company’s filings submitted to BSE.
